Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 2 , Pages 98-105, June 2008

Methods for purifying and detoxifying sodium dodecyl sulfate–stabilized polyacrylate nanoparticles

  • Julio C. Garay-Jimenez, BS

      Affiliations

    • Department of Chemistry, Center for Molecular Diversity in Drug Design, Discovery, and Delivery, University of South Florida, Tampa, Florida, USA
    • ,
  • Ashley Young, BS

      Affiliations

    • Nanopharma Technologies, Inc., Tampa, Florida, USA
    • ,
  • Danielle Gergeres

      Affiliations

    • Department of Chemistry, Center for Molecular Diversity in Drug Design, Discovery, and Delivery, University of South Florida, Tampa, Florida, USA
    • ,
  • Kerriann Greenhalgh, BS, PhD

      Affiliations

    • Department of Chemistry, Center for Molecular Diversity in Drug Design, Discovery, and Delivery, University of South Florida, Tampa, Florida, USA
    • ,
  • Edward Turos, BS, PhD

      Affiliations

    • Department of Chemistry, Center for Molecular Diversity in Drug Design, Discovery, and Delivery, University of South Florida, Tampa, Florida, USA
    • Corresponding Author InformationCorresponding author. Center for Molecular Diversity in Drug Design, Discovery, and Delivery, Department of Chemistry CHE 205, 4202 East Fowler Avenue, University of South Florida, Tampa, FL 33620, USA.

Received 19 October 2007; accepted 20 March 2008. published online 12 May 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The National Institutes of Health (R01 AI01535) and the National Science Foundation (NSF 0419903, NSF 0620572), US Department of Homeland Security (fellowship to K.G.), University of South Florida and the Florida Center of Excellence in Biomolecular Identification and Targeted Therapeutics (for a Graduate Multidisciplinary Scholarship to J.G.), and the University of South Florida Office of Technology Development (for a Florida High Tech Corridor matching grant) all provided support to this study.

 Conflict of interest: Edward Turos is co-inventor on a US patent application by the University of South Florida for the polyacrylate nanoparticle antibiotics, the subject of this publication. Dr. Turos is also co-founder, chief scientific advisor, and shareholder of Nanopharma Technologies, Inc., a University of South Florida spin-out company. Nanopharma Technologies, Inc., has licensed the nanoparticles technology from University of South Florida for potential commercial development.

PII: S1549-9634(08)00037-3

doi:10.1016/j.nano.2008.03.004

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 2 , Pages 98-105, June 2008

Article Tools

* Image Usage & Resolution